m+Medelevator.RU
← Поиск публикаций
Medicine · 2025

COVID-19-induced Brugada phenocopy pattern in a patient with previous myocardial infarction: A case report.

СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ding Lijiang, Jin Huayong

Аннотация

RATIONALE: Coronavirus disease 2019 (COVID-19) can cause electrocardiographic changes, such as ST-segment elevation, by increasing the dispersion of cardiac repolarization or cause delayed depolarization in a localized area of the right ventricular outflow, leading to clinical misdiagnosis.

PATIENT CONCERNS: A 57-year-old man with a history of hypertension and previous myocardial infarction presented to the emergency department with a 12-hour history of fever, chest tightness, and palpitations.

DIAGNOSES: An emergency electrocardiogram (ECG) showed sinus rhythm with abnormal Q waves and ST-segment elevation (0.1-0.35 mV) in leads V1-V3. A positive COVID-19 polymerase chain reaction test and specific ECG metrics, including β-angle measurement and r'-wave triangle base duration, led to the diagnosis of a Brugada phenocopy pattern triggered by COVID-19.

INTERVENTIONS: The patient was treated with an antiplatelet agent (clopidogrel), an antipyretic (acetaminophen) for fever, and oral antivirals (nimatrelvir/ritonavir).

OUTCOMES: After 2 days, his temperature normalized, and a repeat ECG showed resolution of ST-segment elevation.

LESSONS: This case highlights the importance of considering fever-induced Brugada phenocopy in the differential diagnosis of ST-segment elevation in patients with coronary artery disease. Careful ECG analysis, including assessment of the β-angle and r'-wave morphology, is crucial to avoid misdiagnosis of ST-elevation myocardial infarction. Initial management should focus on controlling triggering factors such as fever with antipyretics and antivirals to prevent malignant arrhythmias.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты